Return to homepagePandemic Pact

MSCoViD Scaling of GMP production of human umbilical cord mesenchymal stromal cells for the treatment of CoViD19 patients with moderate to severe acute respiratory distress syndrome

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    N/A

  • Funder

    ANR

  • Principal Investigator

    Danièle Bensoussan

  • Research Location

    France

  • Lead Research Institution

    N/A

  • Research Priority Alignment

    N/A

  • Research Category

    Therapeutics research, development and implementation

  • Research Subcategory

    Pre-clinical studies

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

The MSCoViD project aims to scale up the production under GMP condition of human umbilical cord mesenchymal stromal cells in order to conduct efficacy clinical trials for the treatment of COVID-19 patients with moderate to severe acute respiratory distress syndrome. It will rely on the complementary and multidisciplinary expertise (cell therapy, MSC biology, bioprocess engineering) of each of the partners.